Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating high-dose sequential therapy followed by a single autologous stem cell transplant in multiple myeloma. The…
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: Bortezomib and Bendamustine to Treat Relapsed/Refractory Myeloma [Phase 2]
Phase 2 trial investigating bortezomib and bendamustine for relapsed/refractory multiple myeloma; study terminated with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: Studies in Patients With Multiple Myeloma and Renal Failure Due to Myeloma Cast Nephropathy [Phase 3]
This is a Phase 3 clinical trial update involving patients with multiple myeloma and renal failure due to myeloma cast nephropathy. The stud…
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: FREE Study - Fracture Reduction Evaluation [Phase 4]
Phase 4 trial update on Medtronic Spine's FREE study evaluating fracture reduction in osteopenia and osteoporosis; the study also includes p…
-
CLINICAL_TRIALS trial_result · 2017-12-05Clinical Trial Update: Total Marrow Irradiation for Refractory Acute Leukemia [Phase 1]
A Phase 1 trial evaluating total marrow irradiation for refractory acute leukemia has completed enrollment/status; the study included patien…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases [Phase 1]
Phase 1 trial evaluating the safety of Umbilical Cord Blood T-Regulatory Cell infusion followed by donor cord blood transplant in patients w…
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer [Phase 1]
Phase 1 clinical trial evaluating infusion of regulatory T cells after umbilical cord blood transplant in patients with advanced hematologic…
-
CLINICAL_TRIALS trial_result · 2017-11-30Clinical Trial Update: Trial Studying Maintenance Treatment With Lenalidomide and Dexamethasone Versus Lenalidomide, Dexamethasone and MLN9708 After Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly-diagnosed Symptomatic Multiple Myeloma [Phase 3]
A Phase 3 trial comparing maintenance therapy with lenalidomide and dexamethasone versus lenalidomide, dexamethasone plus ixazomib after aut…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Dalteparin, Lenalidomide, and Low-Dose Dexamethasone in Treating Patients With Previously Untreated Multiple Myeloma [Phase 2]
A Phase 2 trial evaluating dalteparin, lenalidomide, and low-dose dexamethasone in previously untreated multiple myeloma was terminated.
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer [Phase 1, Phase 2]
A Phase 1/2 trial update on using combination chemotherapy and total-body irradiation before donor umbilical cord blood transplant in patien…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma [Phase 2]
A Phase 2 trial evaluating filgrastim compared with sargramostim plus chemotherapy, peripheral stem cell transplantation, and interferon alf…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant [Phase 1]
A Phase 1 trial evaluating donor T cells in high-risk hematologic cancers undergoing donor peripheral blood stem cell transplant was termina…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant [Phase 1]
A Phase 1 trial assessing CpG 7909 in patients who have undergone autologous stem cell transplant has been terminated. The study included pa…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer [NA]
ClinicalTrials.gov entry describes termination of a study evaluating donor umbilical cord blood transplantation for various hematologic canc…
-
CLINICAL_TRIALS trial_result · 2017-11-28Clinical Trial Update: Sequential High-dose Dexamethasone and Response Adopted PAD or VAD Induction Chemotherapy Followed by High-dose Chemotherapy With Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma [Phase 2]
A Phase 2 trial tested sequential high-dose dexamethasone followed by PAD or VAD induction chemotherapy and then high-dose chemotherapy with…
-
CLINICAL_TRIALS trial_result · 2017-11-22Clinical Trial Update: Combination Study of Pomalidomide, Marizomib, and Low-Dose Dexamethasone in Relapsed and Refractory Multiple Myeloma [Phase 1]
Phase 1 study evaluating a triple combination of pomalidomide, marizomib, and low-dose dexamethasone in relapsed and refractory multiple mye…
-
CLINICAL_TRIALS trial_result · 2017-11-22Clinical Trial Update: NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma [Phase 1]
Phase 1 trial update of NPI-0052 (marizomib) and vorinostat in patients with non-small cell lung cancer, pancreatic cancer, melanoma, lympho…
-
CLINICAL_TRIALS trial_result · 2017-11-20Clinical Trial Update: A Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Cancers [Phase 2]
Phase 2 study of Vemurafenib in participants with BRAF V600 mutation–positive cancers, including multiple myeloma and other neoplasms; resul…
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors [NA]
The document reports a completed University of North Carolina clinical trial studying survivorship and psychological outcomes in bone marrow…
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: A Study of the Safety and Activity of the MEK Inhibitor Given Together With the AKT Inhibitor to Patients With Multiple Myeloma or Solid Tumor Cancers [Phase 1]
Phase 1 study evaluating the safety and activity of combining a MEK inhibitor with an AKT inhibitor in patients with multiple myeloma or sol…
-
CLINICAL_TRIALS trial_result · 2017-11-07Clinical Trial Update: "Monoclonal Antibodies for Treatment of Multiple Myeloma. Emphasis on the CD38 Antibody Daratumumab " [Phase 2, Phase 3]
This document reports a completed Phase 2 and Phase 3 trial update evaluating monoclonal antibodies for treating multiple myeloma, with emph…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis [Phase 2]
Phase 2 trial update on high-dose melphalan with autologous stem cell transplantation for multiple myeloma and primary systemic amyloidosis.
-
CLINICAL_TRIALS trial_result · 2017-11-01Clinical Trial Update: A Phase I Open Label Study of the Safety and Tolerability of Elotuzumab (BMS-901608) Administered in Combination With Either Lirilumab (BMS-986015) or Urelumab (BMS-663513) in Subjects With Multiple Myeloma [Phase 1]
Phase I open-label study evaluating the safety and tolerability of elotuzumab in combination with lirilumab or urelumab in patients with mul…
-
CLINICAL_TRIALS trial_result · 2017-10-23Clinical Trial Update: SST0001 (Roneparstat) in Advanced Multiple Myeloma [Phase 1]
Phase 1 study of SST0001 (Roneparstat) in advanced multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2017-10-23Clinical Trial Update: Phase 1 Every-3-Week Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04630) [Phase 1]
A Phase 1 study evaluating every-3-week dosing of SCH 727965 in patients with advanced cancer (including Non-Hodgkin lymphoma and multiple m…